Skip to content
Start your journey

After kidney cancer treatment

Protecting the kidney you have left, blood pressure, imaging surveillance that runs for years because recurrence can be late, and the effects of targeted and immune therapy.

4 min read · Part of Cancer Types

Written by The LifeAfterward editorial team from the sources listed at the end of this page.

Not individually reviewed by a clinician. This page is written from published clinical guidance, listed in full at the end, and is general information rather than medical advice — your own team knows your case. See our editorial standards.

Last checked against its sources · Last updated · Next check due

In short

  • Kidney function needs monitoring for life after a nephrectomy, along with blood pressure — which is both a cause and a consequence here.
  • Surveillance imaging continues for years because kidney cancer can recur late, sometimes more than five years afterwards.
  • Anti-inflammatory painkillers are usually best avoided; check before taking anything over the counter.
  • Targeted and immune therapies bring their own long-term effects, particularly thyroid and blood pressure.

What this means

Two things run in parallel after kidney cancer: watching for recurrence, and protecting kidney function over decades. The second is easy to neglect because it produces no symptoms until late — and it is the part most affected by ordinary decisions like which painkiller you take.

Looking after the kidney you have

  • Blood tests for kidney function at intervals — ask what your baseline is and who monitors it long term.
  • Blood pressure control is the single most important thing you can do for a remaining kidney. Ask for a target and check it regularly.
  • Avoid regular non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen unless your team has said otherwise. Ask which painkillers are safe for you.
  • Stay well hydrated, and be careful with dehydration during illness, heat or hard exercise.
  • Tell any doctor or radiology department that you have one kidney — it affects drug doses and the use of contrast for scans.
  • Contact sports carry a specific risk with a single kidney; ask for advice rather than guessing.

Surveillance, and why it runs so long

  • CT or MRI of the abdomen and chest at intervals based on stage and grade, typically most frequent in the first three years.
  • Kidney cancer is unusual in that recurrence can appear late — years after apparently successful surgery — which is why follow-up often continues well beyond five years.
  • Ask for your schedule in writing and who arranges each scan; this is a follow-up that commonly slips through the gaps once the early years pass.
  • Report persistent cough, bone pain, unexplained weight loss or blood in the urine between appointments.

If you had targeted or immune therapy

  • Tyrosine kinase inhibitors commonly cause high blood pressure, hand-foot skin reactions, thyroid problems, diarrhoea and fatigue. Several persist while on treatment and settle afterwards.
  • Thyroid function should be checked — an underactive thyroid is common and easily treated.
  • Immune checkpoint therapy can cause effects that appear or persist after treatment ends, particularly hormonal — see immunotherapy late effects.
  • If you are on ongoing treatment, living with cancer covers managing it over years.

Family and lifestyle

  • A minority of kidney cancers are linked to inherited syndromes, particularly with young age at diagnosis, multiple tumours or a family history. Ask whether genetic assessment applies — see genetic testing and family risk.
  • Stopping smoking reduces the risk of a further kidney cancer, and helps blood pressure.
  • Weight and blood pressure are the two modifiable factors that matter most here — see exercise after cancer.

What to ask your healthcare team

  • What is my kidney function now, and who monitors it long term?
  • What blood pressure should I be aiming for?
  • Which painkillers are safe for me to take?
  • What is my scan schedule, and how long does it continue?
  • Do I need thyroid or other blood tests after the drug treatment I had?
  • Should I have genetic assessment, given my age and family history?

Save questions to My Journey so you have them in the room, or use a ready-made list.

When to seek medical advice

Contact your healthcare team if you have:

  • Blood in the urine, at any time.
  • Persistent cough, breathlessness or bone pain.
  • Reduced urine output, ankle swelling or unexplained tiredness.
  • Blood pressure readings consistently above your target.
  • Persistent fatigue, weight change or feeling cold — possible thyroid problem.

Get emergency help the same day if you have:

  • Loin pain with fever and feeling very unwell — possible kidney infection.
  • Sudden severe breathlessness or coughing up blood.
  • Passing no urine at all.

If you are worried and unsure, contact your team anyway — they would far rather hear from you unnecessarily than late. What to do in an emergency.

Common questions

Can I take ibuprofen with one kidney?

Usually it is best avoided. Non-steroidal anti-inflammatory drugs reduce blood flow to the kidneys and can affect function, which matters more when you have one. Ask your team which painkillers are safe for you, and tell any doctor or pharmacist that you have had a kidney removed.

How long does follow-up last after kidney cancer?

Often longer than for other cancers, because recurrence can appear late — sometimes more than five years after surgery. Schedules are based on stage and grade, and kidney function and blood pressure monitoring continue for life regardless.

Sources

This page was written from the guidance below and checked against it on . Links are re-checked at each review — see our editorial standards.

  1. ASCO (Cancer.Net). Survivorship
  2. National Comprehensive Cancer Network. NCCN Guidelines for Patients
  3. National Cancer Institute (US). Follow-up medical care after cancer treatment
  4. National Cancer Institute (US). Late effects of cancer treatment
  5. European Society for Medical Oncology. ESMO patient guides